Cargando…
A Model In Vitro Study Using Hypericin: Tumor-Versus Necrosis-Targeting Property and Possible Mechanisms
Hypericin (Hyp) had been explored as a tumor-seeking agent for years; however, more recent studies showed its necrosis-avidity rather than cancer-seeking property. To further look into this discrepancy, we conducted an in vitro study on Hyp retention in vital and dead cancerous HepG2 and normal LO2...
Autores principales: | Li, Yue, Wang, Shuncong, Zhao, Yuanyu, Saiyin, Hexige, He, Xiaoyan, Zhao, Juanzhi, Li, Ling, Talebi, Ali, Huang, Gang, Ni, Yicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168897/ https://www.ncbi.nlm.nih.gov/pubmed/31936002 http://dx.doi.org/10.3390/biology9010013 |
Ejemplares similares
-
Necrosis Avidity: A Newly Discovered Feature of Hypericin and its Preclinical Applications in Necrosis Imaging
por: Jiang, Binghu, et al.
Publicado: (2013) -
Exploring Theranostic Potentials of Radioiodinated Hypericin in Rodent Necrosis Models
por: Li, Junjie, et al.
Publicado: (2012) -
Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models
por: Shao, Haibo, et al.
Publicado: (2015) -
Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy
por: Gao, Long, et al.
Publicado: (2016) -
Sequential Administrations of a Vascular-Disrupting Agent,
High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid
Compound for Eradicating Solid Malignancies
por: Li, Yue, et al.
Publicado: (2022)